who owns semaglutide patent Last week's expiry of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions ICYMI: Shortly after Novo Nordisk's

Molecular mechanisms of ferroptosis and relevance to inflammation

So far, liraglutide and semaglutide alone have 20 million patient years of exposure

A short intake questionnaire cannot replace a comprehensive medical assessment that includes health history review, medication reconciliation, laboratory evaluation, and cardiovascular risk screening

Your provider will set realistic expectations and adjust your plan over time

International News Australia warned about counterfeit anti-choking devices

The visible results, when they happen, are usually gradual enough that month-by-month tracking tells you more than a dramatic before-and-after collage